Specific signaling molecules play a pivotal role in the induction and specification of tissues during early vertebrate embryogenesis. BMP-4 specifies ventral mesoderm differentiation and inhibits neural induction in Xenopus, whereas three molecules secreted from the organizer, noggin, follistatin and chordin dorsalize mesoderm and promote neural induction. Here we report that follistatin antagonizes the activities of BMP-4 in frog embryos and mouse teratocarcinoma cells. In Xenopus embryos follistatin blocks the ventralizing effect of BMP-4. In mouse P19 cells follistatin promotes neural differentiation. BMP-4 antagonizes the action of follistatin and prevents neural differentiation. In addition we show that the follistatin and BMP-4 proteins can interact directly in vitro. These data provide evidence that follistatin might play a role in modulating BMP-4 activity in vivo.
Introduction
The development of the neural system during vertebrate embryogenesis occurs in close temporal and spatial proximity to the events of gastrulation. During gastrulation the three germ layers arise, the embryonic axes get established and the basic body plan is laid down. Although it has been known for more than 70 years through the ground-breaking work of Spemann and Mangold (1924) that the very same embryonic tissue, the dorsal lip of the early amphibian gastrula embryo, provides the signals for both dorsal development and neural induction, the molecular identity of factors involved has remained elusive until recently.
To date the three secreted molecules follistatin, noggin and chordin have been identified as potential neural inducers. These molecules qualify as neural inducers by virtue of their ability to induce neural tissue upon ectopic expression in the Xenopus animal cap assay (Lamb et al., 1993; Hemmati-Brivanlou et al., 1994; Sasai et al., 1995) . These inducers were required to function in the absence of mesoderm, which in turn can induce neural structures on its own in competent ectoderm. noggin, follistatin and chordin are expressed in the organizer tissue of the early frog gastrula (Smith and Harland, 1992; Hemmati-Brivanlou et al., 1994; Sasai et al., 1994) . For noggin and chordin an additional role in dorsal development has been proposed based on extensive characterization of their dorsalizing activity in gain-offunction experiments in Xenopus (Smith and Harland, 1992; Smith et al., 1993; Sasai et al., 1994) .
In similar experiments bone morphogenetic protein (BMP) 4, a member of the TGFb family of secreted growth factors, has revealed characteristics opposite to the ones of noggin, follistatin and chordin. BMP-4 has been shown to exert a potent anti-neuralizing activity Wilson and Hemmati-Brivanlou, 1995) and to ventralize mesoderm (Köster et al., 1991; Dale et al., 1992; Jones et al., 1992 Jones et al., , 1996 Fainsod et al., 1994; Steinbeisser et al., 1995) . In the early amphibian gastrula BMP-4 is expressed in the ventral and lateral marginal zone and in the prospective neuroectoderm of the animal cap region (Fainsod et al., 1994; Schmidt et al., 1995) . Recently it was shown that chordin and noggin can bind to BMP-4 with high affinity (K d = 320 pM and 19 pM, respectively; Piccolo et al., 1996; Zimmerman et al., 1996) . A model has been proposed by which signal transduction through the BMP receptor pathway would lead to ventral and non-neural development, whereas blocking of this signaling by inactivation of the ligand BMP through binding to chordin and noggin would allow neural and dorsal development of the amphibian embryo.
While the potency of the neural and antineural factors in question has been demonstrated convincingly in gain-offunction studies in Xenopus, their endogenous embryonic function has not been addressed to the same extent. Lossof-function alleles in the mouse have been created by targeted mutations of the genes encoding follistatin and BMP-4, and of the BMP receptor type I. While follistatin knockout mice display a number of defects in tissues such as muscle, skeleton, skin, teeth and whiskers, a neural phenotype was not detected (Matzuk et al., 1995) . Loss of BMP-4 function in the mouse resulted in embryonic lethality during gastrulation or early neurulation, with developmental retardation, disorganized posterior structures and reduction of extraembryonic mesoderm (Winnier et al., 1995) . The inactivation of the BMP receptor type I led to defects and lethality at early gastrula stages and a lack of mesodermal tissue in affected embryos, suggesting an essential role for BMPmediated signal transduction at this stage of development (Mishina et al., 1995) .
In the present paper we have studied the role of follistatin in dorsal development of the Xenopus embryo and in neural induction in the mouse system. In addition, we have investigated the functional antagonism between follistatin and BMP-4 in these processes. We show that these secreted factors can bind to each other directly in vitro, suggesting that the dorsalizing and neuralizing functions of noggin, follistatin and chordin are mediated by the same molecular mechanism, the inactivation of the BMP signaling pathway.
Results

follistatin as a dorsal gene
follistatin has been shown to be expressed in the dorsal lip of the blastopore in Xenopus embryos at the onset of gastrulation (stage 10-10.5). As development proceeds, cells along the dorsal midline in the invaginating mesodermal sheet continue to express follistatin transcripts (HemmatiBrivanlou et al., 1994) . The localization of follistatin transcripts suggests that this gene may have a dorsal function in the Xenopus embryo, in addition to its known role as a neural inducer. Sasai et al. (1995) have shown that follistatin is able to dorsalize Xenopus embryos upon injection of synthetic RNA at the eight-cell stage. To obtain a quantitative estimate of the extent of dorsalization induced by different concentrations of follistatin the dorso-anterior index (DAI; Kao and Elinson, 1988) of embryos injected at the four-cell stage was determined. The DAI values observed were 6.8, 7 and 7.4 for embryos injected with 400, 800 and 1200 pg RNA, respectively, whereas control embryos exhibited the normal DAI value of 5 (Fig. 1) .
To further determine a possible involvement of follistatin in dorsal development we analyzed its expression pattern in embryos dorsalized by LiCl-treatment or ventralized by UV-irradiation. Embryos were fixed at stage 10.5-11 and processed for in situ hybridization with a follistatin-specific probe. In dorsalized embryos follistatin became expressed throughout the blastopore (Fig. 2C ), in agreement with the acquired dorsal characteristics of the marginal zone. In contrast, ventralization of the embryo was accompanied by a down-regulation of follistatin transcripts (Fig. 2B ). These observations showed that follistatin behaved like other organizer-specific genes whose expression profile changed in accordance with fate changes of the prospective mesoderm in the marginal zone. To determine whether the expanded follistatin expression plays a role in the dorsalized phenotype of LiCl-treated embryos a rescue experiment was performed. In order to induce a partial loss-of-function of this gene, antisense follistatin RNA was injected into LiCl-treated embryos. For quantitative analysis the DAI of treated and/or injected embryos was determined. Control embryos treated with LiCl exhibited a DAI value of 8.6, as evidenced by enlarged head structures and the lack of axial trunk structures (Fig. 2D) . Antisense follistatin RNA injection resulted in rescue of axial trunk development (DAI = 6.2; Fig. 3E ). These results show that follistatin is in part responsible for the dorsalized phenotype of Li-treated embryos, and that this gene may play a role in dorsal development of normal embryos.
follistatin as part of the dorsal-ventral patterning system
Injections of follistatin mRNA or antisense RNA showed that this gene was able to promote dorsal development. To investigate this effect at the molecular level we analyzed whether the dorsalization induced by follistatin was accompanied by expansion or up-regulation of other dorsal-specific genes. Two genes were chosen for this analysis, gsc and Xnot-2, because in addition to their dorsal-specific expression pattern they have been shown to be repressed by the ventralizing signal, BMP-4 (von Dassow et al., 1993; Fainsod et al., 1994; Steinbeisser et al., 1995) . Embryos injected with follistatin mRNA and processed for whole mount in situ hybridization showed a clear expansion of the gsc and Xnot-2 expression domains (Fig. 3A ,B,D,E). When antisense BMP-4 was injected to create a partial loss-of-function for this ventralizing signal the same result was obtained (not shown). This indicates that follistatin as a dorsal gene can promote the expression of other organizer-specific genes, which is a function opposite to that of the ventralizing growth factor BMP-4.
As a next step we tested whether the reverse correlation also takes place, namely if overexpression of an organizer- specific gene leads to the up-regulation of follistatin expression. To that end we injected gsc mRNA into Xenopus embryos and determined its effect on follistatin expression. Surprisingly, overexpression of gsc prevented the follistatin-expressing cells from invaginating with the mesodermal sheet (Fig. 3C,F) . As expected, overexpression of the ventral gene BMP-4 repressed follistatin expression (not shown).
Previous analysis of the follistatin expression pattern concluded that at later gastrula stages its transcripts are localized to part of the prechordal plate (Hemmati-Brivanlou et al., 1994) . Our in situ hybridization analysis showed that at mid to late gastrulation, follistatin-positive cells can still be observed near the blastopore region suggesting that the follistatin and gsc regions of expression along the dorsal midline do not overlap. In situ hybridizations were performed on stage-matched embryos with probes for both genes. The results further supported the observation that follistatinpositive cells invaginate after the gsc-expressing cells (not shown). Further support for this result was obtained by hybridizing thick horizontal sections (100 mm) of stage 13 embryos with probes for both genes. Fig. 3G shows that along the dorsal midline gsc expression is more rostral (red) than that of follistatin (blue) which it borders caudally. follistatin expression extends towards the posterior end of the embryo. These observations suggest that the follistatin and gsc expression regions are non-overlapping.
For a more quantitative analysis of the interactions observed by in situ hybridization, injected embryos were processed for RT-PCR following RNA extraction. Histone H4 RNA was utilized as a loading control. As observed in the in situ hybridization analysis, gsc expression became upregulated when follistatin was overexpressed or a partial loss-of-function of BMP-4 was induced (Fig. 3H ). Both dorsal-specific genes, gsc and follistatin, were able to down-regulate BMP-4 mRNA expression, in line with the dorsal-ventral antagonism described before (Fig. 3H ). The regulation of follistatin itself, however, turned out to be more complicated. BMP-4 overexpression resulted in the repression of follistatin mRNA accumulation. On the other hand gsc did not affect the level of follistatin transcripts (Fig. 3H ). This observation is in line with the double in situ hybridization which showed that gsc-and follistatinexpressing cells during invagination form two separate populations that do not mix. The observation that gsc overexpression prevents follistatin-positive cells from invaginating further supports this suggestion.
follistatin as a neural inducer in P19 cells
Analysis of the role of follistatin during mouse development has been hampered because of the lack of a neural phenotype and the relatively mild defects of mesodermally derived structures in mutant mice created by a targeted mutation (Matzuk et al., 1995) . In order to assess the involvement of follistatin in neural development we turned to the embryonal carcinoma cell line P19. These cells do not differentiate spontaneously but can be triggered to do so by aggregation and treatment with specific chemical inducers, where retinoic acid at 0.3 mM induces neural differentiation. Following the standard differentiation protocol (Rudnicki and McBurney, 1987) we analyzed the temporal pattern of follistatin expression on Northern blots. Neuronal induction, which was evident morphologically at about day 6 of the experiment, was accompanied by a fast and strong induction of follistatin expression (Fig. 4) . In control cultures that were aggregated and treated with ethanol, which served as the solvent for retinoic acid, a weak induction was observed starting on day 5 (Fig. 4) which probably reflects induction of neural differentiation by the aggregation process.
To test if follistatin can induce neural differentiation on its own, a Xenopus follistatin expression construct, under control of the CMV promoter, was stably transfected into P19 cell cultures. Untreated P19 cells and cultures transfected with the expression vector (pRC/CMV) served as controls. In these experiments cells were not aggregated and no inducers were applied. To enrich for postmitotic neuronal cell types follistatin transfected cultures were additionally selected with cytosine arabinoside (see Section 4 for details). In keeping with its known role as a neural inducer in Xenopus, follistatin expression was sufficient to induce neural differentiation in P19 cells (Fig. 5C ). This process was characterized by cell morphology (Fig. 5) and by staining with antibodies specific for the neuronal marker neurofilament (NF)-M (Fig. 5C ), the pan-neural marker N-CAM (not shown) and the glia marker glial fibrillary acidic protein (not shown). Untransfected P19 cells (Fig. 5A) and Fig. 4 . follistatin mRNA is expressed in neural induced P19 cells. Northern blot analysis of P19 cells induced towards neural differentiation by aggregation and the addition of 0.3 mM retinoic acid. Control cultures were treated similarly with ethanol which served as the solvent for retinoic acid. RNA samples were prepared at 24 h intervals for a total of 10 days. glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was used as a loading control.
vector transfected cells (Fig. 5B) did not differentiate into neural cell types under these conditions.
The antagonism between follistatin and BMP-4
The experiments presented demonstrate the role of follistatin in dorsal development of the frog Xenopus and in neural induction in mouse embryonal carcinoma cells. In Xenopus embryos BMP-4 represents a growth factor that counteracts both these processes by ventralizing the mesoderm and inhibiting neural induction. We therefore tested the possibility of a functional antagonism of these two secreted factors.
To analyze the interplay of follistatin and BMP-4 during dorsal development, RNA microinjection experiments into Xenopus four-cell embryos were performed. Injection of BMP-4 mRNA (1200 pg/embryo) resulted in strongly ventralized embryos (DAI = 0.78; n = 40; Fig. 6B ). Injection of BMP-4 (1200 pg/embryo) together with follistatin mRNA (800 pg/embryo) resulted in the complete rescue of the BMP-4 effects as evidenced from a DAI value of 5.26 (n = 56; Fig. 6C ). The DAI of embryos injected with 800 pg follistatin RNA alone was in the order of 7. The lower values obtained in embryos co-injected with BMP-4 suggest antagonistic activities between these two overexpressed proteins. Further increase in the amount of follistatin mRNA to 1600 pg/embryo resulted in a dorsalization of the co-injected embryos (DAI = 6.35; n = 23; not shown). Control embryos including uninjected embryos and prolactin-injected embryos (1600 pg/embryo; Fig. 6A ) gave DAI values of 5 (n = 82) and 4.93 (n = 44), respectively. These experiments demonstrate that follistatin and BMP-4 can antagonize each other upon ectopic overexpression in vivo.
To assess the interaction of BMP-4 and follistatin during neural induction, recombinant human (rh) BMP-4 protein was added to P19 cell cultures stably expressing follistatin. The neural-inducing activity of follistatin was quantitatively antagonized by addition of rhBMP-4 protein at concentrations Ͼ10 ng/ml (not shown). At the molecular level, addition of rhBMP-4 resulted in the dose-dependent reduction of N-CAM RNA expression in P19 monolayer cultures stably expressing Xenopus follistatin. RT-PCR analysis revealed a reduction to background levels after 8 days of culture in the presence of 20 ng/ml rhBMP-4 (Fig. 6D) . Control cultures transfected with the expression vector pRC/CMV and grown under identical conditions with and without the addition of rhBMP-4 did not reveal any N-CAM RNA expression (not shown). These experiments indicate a role of follistatin in neural differentiation of P19 cells. Taken together, these data suggest a functional antagonism between BMP-4 and follistatin during mesodermal and neural development in Xenopus and mouse P19 teratocarcinoma cells.
Direct binding between follistatin and BMP-4
Mechanistically, the antagonism between follistatin and BMP-4 could be due to alterations at the transcriptional level or to a direct protein-protein interaction of the two secreted proteins. In the case of BMP-4 an effect on the transcription rate of follistatin could be mediated by the downstream signaling cascade (Massague, 1996) . For the reverse interaction, transcriptional regulation of BMP-4 through a follistatin-mediated dorsal-specific signaling pathway seems unlikely as no experimental evidence for follistatin function through a receptor has been obtained as yet. On the other hand, the molecular analysis presented in Fig. 3 clearly shows that follistatin represses BMP-4 transcription. This apparent paradox could be resolved, however, if one would assume a direct interaction of the two proteins. In such a scenario the BMP-4 transcriptional repression would be an indirect effect of the extracellular binding of follistatin to BMP-4 that would prevent BMP-4 from positively regulating its own transcription (Dale et al., 1992; Shapira and Fainsod, unpublished observations) . A direct interaction of follistatin and BMP-4 seems conceivable, particularly as follistatin inhibits the function of another member of the TGFb family, activin, by such a mechanism (Nakamura et al., 1990) .
To investigate a possible direct interaction between follistatin and BMP-4 we performed in vitro binding studies. To that end the Xenopus follistatin protein (Hemmati-Brivanlou et al., 1994) was tagged using a myc epitope (Evan et al., 1985) and expressed under the control of the CMV promoter in human kidney 293 cells. Serum-free conditioned medium from these cultures was incubated with rhBMP-4 protein, followed by immunoprecipitation with anti-myc antibodies. The precipitated proteins were separated on polyacrylamide gels under non-reducing conditions and analyzed by immunoblotting with a monoclonal anti-BMP-4 antibody (Masuhara et al., 1995) . A band identical in size to the recombinant BMP-4 protein and migrating as previously described (Masuhara et al., 1995) was only detected in samples that contained the follistatin-myc protein (Fig. 7) . No BMP-4 specific band was seen when conditioned media from vector-transfected cells (Fig. 7) or when protein extracts were prepared from the transfected cells (Fig. 7) . When untagged follistatin was transfected and binding reactions were precipitated with a mouse polyclonal follistatin antibody a weak band of the correct size was also detected (Fig. 7) . The weak band was attributed to the low activity of the anti-follistatin antibody. These co-precipitation experiments show that BMP-4 and follistatin proteins can interact directly in vitro.
Discussion
follistatin as an organizer gene
The main functions of the gastrula organizer (Spemann's organizer, Hensen's node) are the formation of dorsal/medial types of mesoderm such as notochord, the dorsalization of paraxial mesoderm and the secretion of signals that trigger neural induction. In previous work it was shown that follistatin can induce neural differentiation without a requirement for mesoderm (Hemmati-Brivanlou et al., 1994; Sasai et al., 1995) . These experiments established follistatin as a direct neural inducer capable of performing some of the functions attributed to the organizer or its descendants.
In the present work we have shown that follistatin overexpression can induce a dose-dependent dorsalization of the Xenopus embryo. In addition, its expression becomes expanded throughout the marginal zone when the fate of the mesoderm is dorsalized by a different treatment such as LiCl. Partial loss-of-function of follistatin by antisense RNA injection into LiCl dorsalized embryos showed that this activity was necessary for the dorsalized phenotype. At the molecular level, follistatin not only induced the dorsalization of the embryo but promoted the expansion of the expression domains of other organizer-specific genes such as gsc and Xnot-2. All these results taken together show that follistatin can mediate in part the dorsal identity of mesoderm in the embryo. Two other secreted proteins, noggin and chordin are also localized in the organizer region and are able to mediate most organizer functions (Smith and Harland, 1992; Lamb et al., 1993; Smith et al., 1993; Sasai et al., 1994; Sasai et al., 1995) . All three proteins belong to different families of proteins but they can dorsalize mesoderm and induce neural differentiation in the absence of mesoderm. This observation suggests that follistatin, noggin and chordin are part of the organizer signaling network which is needed to generate a complete organizer.
follistatin as an antagonist of BMP-4
BMP-4 has been shown to play an important role in the spatial restriction of the organizer activity. This member of the TGFb family provides a strong ventralizing signal in the embryo (Dale et al., 1992; Jones et al., 1992; Jones et al., 1996) . It can prevent the formation of a fully active organizer when injected in its vicinity by repressing the activity of organizer-specific genes (von Dassow et al., 1993; Fainsod et al., 1994; Steinbeisser et al., 1995) . BMP-4 has also been shown to prevent neural induction in animal cap assays and to promote epidermal development Wilson and Hemmati-Brivanlou, 1995; Xu et al., 1995) . Therefore, BMP-4 also antagonizes both organizer functions, dorsalization of the mesoderm and neural induction. In animal cap assays, BMP-4 proved to be an efficient antagonist of both noggin and chordin (Re'em-Kalma et al., 1995; Sasai et al., 1995) .
To test the antagonism between follistatin and BMP-4 we used the whole embryo ventralized by ectopically expressed BMP-4 as the test system. Overexpression of follistatin very efficiently prevented the ventralizing activity of BMP-4. Injection of higher amounts of follistatin mRNA resulted in further dorsalization of the embryos, suggesting that the endogenous BMP-4 protein was also antagonized. Further support for the existence of such an antagonism in vivo was obtained in tissue culture. It has been known for some time that in F9 embryonal carcinoma cells prior to differentiation, BMP-4 is expressed. Induction of differentiation into parietal endoderm by a combination of retinoic acid and cAMP results in an 11-12-fold increase and decrease of BMP-2 and BMP-4, respectively (Rogers et al., 1992) . In this study the P19 cell line was chosen because it can be induced to differentiate into neural cells with high efficiency by retinoic acid treatment. Concomitant with the neural induction, follistatin mRNA expression was induced providing evidence for a role of follistatin in neural induction in mouse embryonal carcinoma cells. More directly, overexpression of follistatin in P19 cells was sufficient to induce their differentiation without the need for aggregation and/or Fig. 7 . Direct interaction between follistatin and BMP-4 proteins. Co-precipitation of BMP-4 and follistatin. Conditioned medium or cell extracts from cells transfected either with plasmid vector (pCDNA3), a Xenopus follistatin expression vector or a myc-tagged follistatin expression vector were subjected to binding with BMP-4. The complex was immunoprecipitated with anti-myc or anti-follistatin-specific antibodies, separated on non-reducing polyacrylamide gels and analyzed by immunoblotting with anti-BMP-4 monoclonal antibodies. The position of rhBMP-4 protein on the gel is marked by an arrow. retinoic acid. In the light of the known neural-inducing activity of follistatin in Xenopus these results raise the possibility that follistatin may play a role in neurulation in the mouse as well. In embryonal carcinoma cells the neuralinducing activity of follistatin could be blocked by the addition of BMP-4 protein to the culture medium. Regardless of the function of follistatin in the induction of neural differentiation of P19 cells, BMP-4 could efficiently block this induction and the expression of neural markers like N-CAM, further demonstrating the antagonism between these two proteins. Support for these observations comes from experiments where it was shown that follistatin efficiently antagonizes BMP-7, another member of the BMP family (Yamashita et al., 1995) .
The mode of action of follistatin
follistatin was initially identified as an activin-binding protein which prevents the interaction of this growth factor with its receptor (Nakamura et al., 1990) . Therefore, follistatin was known as a protein capable of binding to some but not all members of the TGFb family (Nakamura et al., 1990) . Because BMP-4, like activin, is a member of the TGFb family it was very tempting to suggest that the antagonism between follistatin and BMP-4 was achieved by direct interaction between these two proteins. Immunoprecipitation experiments revealed that BMP-4 was co-precipitated together with follistatin following binding in vitro. This mode of action of follistatin suggests that the antagonism observed in Xenopus embryos could be achieved in vivo by binding to BMP-4. As a consequence, signaling through the BMP receptors would be inhibited, ventralization and epidermal differentiation would be prevented and neuralization and dorsalization could occur. In the case of P19 cells, the overexpressed follistatin would interact with a BMP protein that prevents the embryonal carcinoma cells from undergoing differentiation. To corroborate that the role of follistatin in neural induction is mediated through the inhibition of BMP signaling, cells were transfected with a dominant negative BMP receptor. Introduction of this receptor, which can mediate signaling of several BMP proteins (Massague, 1996) , induced neural differentiation of P19 cells without further treatment (Deißler and Blum, unpublished results). This experiment suggests that a member of the BMP family helps maintain the P19 embryonal carcinoma cells in their undifferentiated state. Further support for this suggestion comes from the observation that the endogenous follistatin gene is strongly activated in P19 cells with the induction of differentiation. To identify the prospective BMP in the undifferentiated cells a screen by RT-PCR was performed for BMP-4, BMP-2 and BMP-7. The results showed that BMP-2 and BMP-7 were highly expressed in undifferentiated P19 cells whereas BMP-4 RNA levels were at the detection limit (Deißler and Blum, unpublished observations) . As follistatin has been shown to antagonize BMP-7 in the embryo (Yamashita et al., 1995) , and because of high identity between the BMP proteins (Hogan, 1996) and the specificity of the BMP receptor we conclude that the dominant negative BMP receptor prevents signaling of these BMP proteins. It seems likely that follistatin can bind to BMP-2 and/or BMP-7 as well, and that an excess of BMP-4 can prevent this interaction.
The organizer as an antagonist of BMP-4: a model
In the Xenopus embryo BMP-4 is expressed during gastrulation along the marginal zone and in the animal cap. The only region where BMP-4 transcripts are absent is the organizer region itself (Fainsod et al., 1994; Schmidt et al., 1995) . This localization is in perfect agreement with the activities attributed to this gene. Although some maternal BMP-4 transcripts have been detected (Dale et al., 1992; Jones et al., 1992) a main surge in expression of this gene takes place with the onset of gastrulation (Fainsod et al., 1994) . Experimental treatments that result in the ventralization of the embryo, UV-irradiation or suramin treatment, result in the precocious activation of BMP-4 transcription (Fainsod et al., 1994) . The capability of BMP-4 to repress dorsal-specific genes suggests that the 1 h delay in transcriptional activation of BMP-4 as compared to the organizerspecific genes allows their unencumbered expression at the onset of gastrulation.
Together with follistatin, three organizer proteins have been identified whose biochemical function is to sequester BMP proteins and prevent signaling through their receptors (Piccolo et al., 1996; Zimmerman et al., 1996) . All three genes chordin, follistatin and noggin can perform the main activities attributed to the organizer and its derivatives (Smith and Harland, 1992; Lamb et al., 1993; Smith et al., 1993; Hemmati-Brivanlou et al., 1994; Sasai et al., 1994; Sasai et al., 1995) . Transcripts of all three genes appear in the organizer region just prior to the onset of gastrulation and their transcripts continue for some time to be localized in the invaginating dorsal midline mesoderm. This pattern of expression suggests that they can perform the mesodermal patterning function in the dorsal lip of the blastopore before cells invaginate. As gastrulation proceeds and the cells of the dorsal mesoderm involute, these secreted proteins can perform their neural-inducing function.
The neural inducer has been proposed to be secreted from the dorsal mesodermal cells and to act upon the overlaying animal cap. As development proceeds transcripts of all three genes take different positions along the dorsal midline, thus generating partially overlapping patterns of expression. Comparison of the dissociation constants for BMPs and their receptors (K d = 35-250 pM; Koenig et al., 1994; Iwasaki et al., 1995) , noggin and BMP-4 (K d = 20 pM; Zimmerman et al., 1996) , chordin and BMP-4 (K d = 300 pM; Piccolo et al., 1996) and activin and follistatin (K d = 1.3-200 pM; Nakamura et al., 1990; Schneyer et al., 1994) suggests a picture of high affinity interactions. If the affinity of follistatin to BMP-4 is in the same range as that for activin then all three organizer genes will bind BMP-4 with similar affinities and more comparative studies will be required to understand the differences and synergism between these proteins. In this light the loss of function studies for noggin and follistatin in the mouse have to be interpreted. The lack of a neural phenotype in follistatin null mice might be caused by the presence of chordin and noggin which could partially compensate the defect.
Although expression of BMP-7 and BMP-2 can be detected in the embryo (Clement et al., 1995; Hawley et al., 1995; Hemmati-Brivanlou and Thomsen, 1995; Steinbeisser and Fainsod, unpublished observations) it appears that all three BMP binding factors are mainly functioning against BMP-4 as this member of the TGFb family seems to be one of the main signals opposed to the organizer. In the process of neural induction BMP-7 transcripts can be detected in the animal cap region (Hawley et al., 1995; Steinbeisser and Fainsod, unpublished observations) . BMP-7 also plays a role in preventing neural differentiation as shown by dominant negative BMP-7 constructs (Hawley et al., 1995) . The BMP proteins have been shown to be capable of forming homo-and heterodimers with different biological properties (Aono et al., 1995) . Therefore, some of the activities of the BMP binding proteins, follistatin, chordin and noggin, might not be directed solely against BMP-4 but against other BMPs as well.
Experimental procedures
RNA preparation and injection
Capped RNA for injection was prepared using the CAP Scribe (Boehringer) or RiboMax (Promega) kits as described (Fainsod et al., 1994; Steinbeisser et al., 1995) . The cap analog/GTP ratio used was 5:1. Injections were performed at the four-cell stage by injecting about 4 nl in each blastomere in the equatorial region.
Whole mount in situ hybridization
Digoxigenin-labelled RNA probes were transcribed using the RiboMax kit (Promega) utilizing the RNA labelling mix (Boehringer). Localization of transcripts by in situ hybridization was performed as described (Fainsod et al., 1994) .
RT-PCR analysis
RNA from embryos was prepared by the phenol/guanidinium thiocyanate method using the TriPure reagent (Boehringer). RT-PCR was performed as described by Fainsod et al. (1994) . The primers used were: BMP-4, 5′ GCATG-TAAGGATAAGTCGATC and 5′ GATCTCAGACTCA-ACGGCAC resulting in a 478 bp fragment after 23 cycles; gsc, 5′ GGAGAGGACTGCAGTCTGCATG and 5′ TCTA-GAGTCGACTCAACTCTGCAGCTCAGTCCTGGA resulting in a 590 BP fragment after 31 cycles; follistatin, 5′ CAGTGCAGCGCTGGAAAG and 5′ TGCGTTGCGGTA-ATTCAC resulting in a 229 bp fragment after 31 cycles; histone H4, 5′ CGGGATAACATTCAGGGTATCACT and 5′ ATCCATGGCGGTAACTGTCTTCTT resulting in a 188 bp product after 19 cycles; N-CAM, 5′ ATTCTT-CCTGTGTCAAGTGG and 5′ TTGTTGGACAGGAC-TATGAAC, resulting in a 404 bp product after 32 cycles; HPRT, 5′ GCTGGTGAAAAGGACCTCT and 5′ CACAG-GACTAGAACACCTGC, resulting in a 249 bp product after 28 cycles. Quantitation was performed on a Phosphoimager (Fuji) and the results were normalized to the level of histone H4 and HPRT transcripts, for analysis of embryonic and P19 cell RNA, respectively.
Axis perturbation
UV-treatment of embryos was performed 30 min after the fertilization by placing the embryos in 1 × modified Barth's solution on quartz slides. Embryos were irradiated for 60 s using a GL 25 lamp (UVP). The embryos were not moved for 1 h after the UV-treatment. To achieve a partialLi treatment embryos at the 32-cell stage were incubated for 20 min in a solution of 120 mM LiCl in 0.1 × Barth's solution. After the treatment the embryos were washed twice in 0.1 × Barth's and then incubated in the same solution at room temperature. For a full LiCl treatment the incubation time was extended to 35 min (Fainsod et al., 1994) .
P19 culture conditions and treatments
P19 cells were cultured in DMEM with the addition of 10% fetal bovine serum. The differentiation protocol into neural cell types using retinoic acid as an inducer was as described in Rudnicki and McBurney (1987) . For transfection 10 7 cells were electroporated with 50 mg plasmid DNA, and replated on gelatin-coated glass slides which were placed in tissue culture dishes (5 × 10 5 cells/10 cm dish). The medium was changed every other day; G418 selection (400 mg/ml) was started after 48 h, cytosine arabinoside selection (5 mg/ml) 72 h after transfection. rhBMP-4 was added to the medium at the indicated concentrations and was present for the entire culture period. After 10-14 days cells were fixed for immunohistochemistry and stained with antibodies following standard protocols.
Follistatin-myc/BMP-4 immunoprecipitation and immunodetection
The myc epitope sequence recognized by the 9E10 monoclonal antibody (Evan et al., 1985) was added to the follistatin cDNA by polymerase chain reaction. The follistatin cDNA was amplified with primers that add the myc sequence EQKLISEEDL at the carboxy terminal end of the protein sequence. The myc-tagged follistatin was subcloned into an eukaryotic expression vector (pCDNA3; Invitrogen) and transiently transfected into 293 cells using DOTAP (Boehringer) under the conditions recommended by the manufacturer. Conditioned medium (DMEM with no serum) collected from the second to the fourth day after transfection was concentrated five-fold in a centricon-10 unit (Amicon) was utilized as a source of follistatin-myc. Binding reactions between rhBMP-4 (200 ng; Genetics institute, Cambridge, MA) and follistatin-myc (30 ml) were carried out in binding buffer (136.9 mM NaCl, 5.37 mM KCl, 1.26 mM CaCl 2 , 0.64 mM MgSO 4 , 0.34 mM Na 2 HPO 4 , 0.44 mM KH 2 PO 4 , 0.49 mM MgCl 2 , 25 mM HEPES, 0.5% BSA; Graff et al., 1994 ) for 1.5 h at room temperature and then followed by immunoprecipitation under standard conditions using anti-myc (9E10) ascites fluid (1 ml) and protein A-agarose (Sigma). The immunoprecipitate was subjected to immunodetection with anti-BMP-4 following electrophoretic separation under nonreducing conditions and transfer to nitrocellulose membranes. Detection of BMP-4 was performed with ECL (Amersham) following the manufacturer's conditions.
